For many early-stage startups, choosing between a convertible note and a SAFE (Simple Agreement for Future Equity) is one of the first critical legal and strategic financing decisions. While both ...

SAINT HELIER, JE / ACCESS Newswire / January 14, 2026 / Caledonia Mining Corporation Plc (“Caledonia”), a gold production, ...

You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re open to a convertible note, and suddenly you’re deep in legal blog posts at ...

Indaptus Therapeutics raised $5.7 million through the sale of convertible promissory notes and warrants for R&D purposes. Indaptus Therapeutics, Inc., a clinical stage biotech company, announced the ...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) today announced that it has entered into exchange agreements (the “Exchange Agreements”) with a limited number ...

Convertible notes represent a debt owed by the startup to the investor. The agreement is that the investor provides a loan to the startup in exchange for a convertible note. The loan accrues interest ...

Opportunistic capital raise for general corporate purposes Either net proceeds from this offering or cash on hand to be used to purchase cash-settled capped calls to offset economic dilution up to a ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Super Micro Computer, Inc. (NASDAQ: SMCI) (“Supermicro” or the “Company”), a Total IT Solution Manufacturer for AI, Cloud, Storage, and 5G/Edge, today announced the ...

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (IREN) (“IREN”) today announced its intention to commence a registered direct offering of ordinary shares (the “Offering”) to a limited number ...

MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced ...

$1.15 billion 0.00% Convertible Senior Notes offering (27.50% conversion premium) The repurchase of approximately $460 million of the common stock from investors in the Convertible Notes CleanSpark ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a ...